15-deoxy-Δ12,14-prostaglandin J2 inhibits the expression of microsomal prostaglandin E synthase type 2 in colon cancer cells

Journal of Lipid Research

Volumn 47, Issue 5, 2006, Pages 1071-1080

  Schröder, Oliver ^a   Yudina, Yulyana ^a   Sabirsh, Alan ^b   Zahn, Nadine ^a   Haeggström, Jesper Z ^b   Stein, Jürgen ^a  

^a GOETHE UNIVERSITY   (Germany)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Colorectal cancer; Cyclopentenone prostaglandins; Feedback control; Proliferation; Prostaglandin E2; Redox status

Indexed keywords

15 DEOXY DELTA(12,14) PROSTAGLANDIN J2; 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J2; DRUG DERIVATIVE; IMMUNOGLOBULIN RECEPTOR; ISOMERASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROSTAGLANDIN A; PROSTAGLANDIN A2; PROSTAGLANDIN D2; PROSTAGLANDIN D2 RECEPTOR; PROSTAGLANDIN E SYNTHASE; PROSTAGLANDIN E2; PROSTAGLANDIN RECEPTOR;

ARTICLE; CELL STRAIN CACO 2; CELL STRAIN HCT116; COLON TUMOR; DOWN REGULATION; DRUG ANTAGONISM; ENZYMOLOGY; HUMAN; METABOLISM; MICROSOME; PHYSIOLOGY;

CACO-2 CELLS; COLONIC NEOPLASMS; DINOPROSTONE; DOWN-REGULATION; HCT116 CELLS; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; MICROSOMES; PPAR GAMMA; PROSTAGLANDIN D2; PROSTAGLANDINS A; RECEPTORS, IMMUNOLOGIC; RECEPTORS, PROSTAGLANDIN;

EID: 33646814714     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M600008-JLR200     Document Type: Article

References (44)

1. Gwyn, K., and F. A. Sinicrope. 2002. Chemoprevention of colorectal cancer. Am. J. Gastroenterol. 97: 13-21.
2. Rigas, B., I. S. Goldman, and L. Levine. 1993. Altered eicosanoid levels in human colon cancer. J. Lab. Clin. Med. 122: 518-523.
3. Eberhart, C. E., R. J. Coffey, A. Radhika, F. M. Giardiello, S. Ferrenbach, and R. N. DuBois. 1994. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology. 107: 1183-1188.
4. Vane, J. R. 1971. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat. New Biol. 231: 232-235.
5. Warner, T. D., and J. A. Mitchell. 2004. Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic. FASEB J. 18: 790-804.
6. Pugh, S., and G. A. Thomas. 1994. Patients with adenomatous polyps and carcinomas have increased colonic mucosal prostaglandin E2. Gut. 35: 675-678.
7. Turini, M. E., and R. N. DuBois. 2002. Cyclooxygenase-2: a therapeutic target. Annu. Rev. Med. 53: 35-57.
8. Watanabe, K., T. Kawamori, S. Nakatsugi, T. Ohta, S. Ohuchida, H. Yamamoto, T. Maruyama, K. Kondo, F. Ushikubi, S. Narumiya, et al. 1999. Role of the prostaglandin E receptor subtype EP1 in colon carcinogenesis. Cancer Res. 59: 5093-5096.
9. Mutoh, M., K. Watanabe, T. Kitamura, Y. Shoji, M. Takahashi, T. Kawamori, K. Tani, M. Kobayashi, T. Maruyama, K. Kobayashi, et al. 2002. Involvement of prostaglandin E receptor subtype EP(4) in colon carcinogenesis. Cancer Res. 62: 28-32.
10. Kawamori, T., N. Uchiya, T. Sugimura, and K. Wakabayashi. 2002. Enhancement of colon carcinogenesis by prostaglandin E2 administration. Carcinogenesis. 24: 985-990.
11. Yoshimatsu, K., D. Golijanin, P. B. Paty, R. A. Soslow, P. J. Jakobsson, R. A. DeLellis, K. Subbaramaiah, and A. J. Dannenberg. 2001. Inducible microsomal prostaglandin E synthase is overexpressed in colorectal adenomas and cancer. Clin. Cancer Res. 7: 3971-3976.
12. Murakami, M., K. Nakashima, D. Kamei, S. Masuda, Y. Ishikawa, T. Ishii, Y. Ohmiya, K. Watanabe, and I. Kudo. 2003. Cellular prostaglandin E2 production by membrane-bound prostaglandin E synthase-2 via both cyclooxygenases-1 and -2. J. Biol. Chem. 278: 37937-37947.
13. Takashima, T., Y. Fujiwara, K. Higuchi, T. Arakawa, Y. Yano, T. Hasuma, and S. Otani. 2001. PPAR-gamma ligands inhibit growth of human esophageal adenocarcinoma cells through induction of apoptosis, cell cycle arrest and reduction of ornithine decarboxylase activity. Int. J. Oncol. 19: 465-471.
14. Chen, Z. Y., and C. C. Tseng. 2005. 15-Deoxy-Delta12,14 prostaglandin J2 up-regulates Kruppel-like factor 4 expression independently of peroxisome proliferator-activated receptor gamma by activating the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signal transduction pathway in HT-29 colon cancer cells. Mol. Pharmacol. 68: 1203-1213.
15. Gilroy, D. W., P. R. Colville-Nash, D. Willis, J. Chivers, M. J. Paul-Clark, and D. A. Willoughby. 1999. Inducible cyclooxygenase may have anti-inflammatory properties. Nat. Med. 5: 698-701.
16. Inoue, H., T. Tanabe, and K. Umesono. 2000. Feedback control of cyclooxygenase-2 expression through PPARgamma. J. Biol. Chem. 275: 28028-28032.
17. Tsubouchi, Y., Y. Kawahito, M. Kohno, K. Inoue, T. Hla, and H. Sano. 2001. Feedback control of the arachidonate cascade in rheumatoid synoviocytes by 15-deoxy-Delta(12,14)-prostaglandin J2. Biochem. Biophys. Res. Commun. 283: 750-755.
18. Quraishi, O., J. A. Mancini, and D. Riendeau. 2002. Inhibition of inducible prostaglandin E(2) synthase by 15-deoxy-Delta(12,14)-prostaglandin J(2) and polyunsaturated fatty acids. Biochem. Pharmacol. 63: 1183-1189.
19. Ulrich, S., A. Wächtershäuser, S. Loitsch, A. von Knethen, B. Brüne, and J. Stein. 2005. Activation of PPARgamma is not involved in butyrate-induced epithelial cell differentiation. Exp. Cell Res. 310: 196-204.
20. Singer, V. L., L. J. Jones, S. T. Yue, and R. P. Haugland. 1997. Characterization of PicoGreen reagent and development of a fluorescence-based solution assay for double-stranded DNA quantitation. Anal. Biochem. 249: 228-238.
21. Thorén, S., and P. J. Jakobsson. 2000. Coordinate up- and downregulation of glutathione-dependent prostaglandin E synthase and cyclooxygenase-2 in A549 cells. Inhibition by NS-398 and leukotriene C4. Eur. J. Biochem. 267: 6428-6434.
22. Wright, D. H., K. M. Metters, M. Abramovitz, and A. W. Ford-Hutchinson. 1998. Characterization of the recombinant human prostanoid DP receptor and identification of L-644,698, a novel selective DP agonist. Br. J. Pharmacol. 123: 1317-1324.
23. Hata, A. N., R. Zent, M. D. Breyer, and R. M. Breyer. 2003. Expression and molecular pharmacology of the mouse CRTH2 receptor. J. Pharmacol. Exp. Ther. 306: 463-470.
24. Hawcroft, G., S. H. Gardner, and M. A. Hull. 2004. Expression of prostaglandin D2 receptors DP1 and DP2 by human colorectal cancer cells. Cancer Lett. 210: 81-84.
25. Valko, M., H. Morris, and M. T. Cronin. 2005. Metals, toxicity and oxidative stress. Curr. Med. Chem. 12: 1161-1208.
26. Qiao, L., V. Kozoni, G. J. Tsioulias, M. I. Koutsos, R. Hanif, S. J. Shiff, and R. Rigas. 1995. Selected eicosanoids increase the proliferation rate of human colon carcinoma cell lines and mouse colonocytes in vivo. Biochim. Biophys. Acta. 1258: 215-223.
27. Sheng, H., J. Shao, M. K. Washington, and R. N. DuBois. 2001. Prostaglandin E2 increases growth and motility of colorectal carcinoma cells. J. Biol. Chem. 276: 18075-18081.
28. Cassano, G., G. Gasparre, F. Susca, C. Lippe, and G. Guanti. 2000. Effect of prostaglandin E(2) on the proliferation, Ca(2+) mobilization and cAMP in HT-29 human colon adenocarcinoma cells. Cancer Lett. 152: 217-222.
29. Dommels, Y. E., M. M. Haring, N. G. Keestra, G. M. Alink, P. J. van Bladeren, and B. van Ommen. 2003. The role of cyclooxygenase in n-6 and n-3 polyunsaturated fatty acid mediated effects on cell proliferation, PGE(2) synthesis and cytotoxicity in human colorectal carcinoma cell lines. Carcinogenesis. 24: 385-392.
30. Gupta, R. A., and R. N. Dubois. 2001. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat. Rev. Cancer. 1: 11-21.
31. Kamei, D., M. Murakami, Y. Nakatani, Y. Ishikawa, T. Ishii, and I. Kudo. 2003. Potential role of microsomal prostaglandin E synthase-1 in tumorigenesis. J. Biol. Chem. 278: 19396-19405.
32. Murakami, M., H. Naraba, T. Tanioka, N. Semmyo, Y. Nakatani, F. Kojima, T. Ikeda, M. Fueki, A. Ueno, S. Oh, et al. 2000. Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2. J. Biol. Chem. 275: 32783-32792.
33. Tanioka, T., Y. Nakatani, N. Semmyo, M. Murakami, and I. Kudo. 2000. Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis. J. Biol. Chem. 275: 32775-32782.
34. Sonoshita, M., K. Takaku, N. Sasaki, Y. Sugimoto, F. Ushikubi, S. Narumiya, M. Oshima, and M. M. Taketo. 2001. Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc(Delta 716) knockout mice. Nat. Med. 7: 1048-1051.
35. Kawamori, T., T. Kitamura, K. Watanabe, N. Uchiya, T. Maruyama, S. Narumiya, T. Sugimura, and K. Wakabayashi. 2005. Prostaglandin E receptor subtype EP(1) deficiency inhibits colon cancer development. Carcinogenesis. 26: 353-357.
36. Shoji, Y., M. Takahashi, T. Kitamura, K. Watanabe, T. Kawamori, T. Maruyama, Y. Sugimoto, M. Negishi, S. Narumiya, T. Sugimura, et al. 2004. Downregulation of prostaglandin E receptor subtype EP3 during colon cancer development. Gut. 53: 1151-1158.
37. Wang, D., and R. N. Dubois. 2006. Prostaglandins and cancer. Gut. 55: 115-122.
38. Tontonoz, P., E. Hu, R. A. Graves, A. I. Budavari, and B. M. Spiegelman. 1994. mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev. 8: 1224-1234.
39. Jiang, C., A. T. Ting, and B. Seed. 1998. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature. 391: 82-86.
40. Sarraf, P., E. Mueller, D. Jones, F. J. King, D. J. DeAngelo, J. B. Partridge, S. A. Holden, L. B. Chen, S. Singer, C. Fletcher, et al. 1998. Differentiation and reversal of malignant changes in colon cancer through PPARgamma. Nat. Med. 4: 1046-1052.
41. Rossi, A., P. Kapahi, G. Natoli, T. Takahashi, Y. Chen, M. Karin, and M. G. Santoro. 2000. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase. Nature. 403: 103-108.
42. Cernuda-Morollon, E., E. Pineda-Molina, F. J. Canada, and D. Perez-Sala. 2001. 15-Deoxy-Delta 12,14-prostaglandin J2 inhibition of NF-kappaB-DNA binding through covalent modification of the p50 subunit. J. Biol. Chem. 276: 35530-35536.
43. Gayarre, J., K. Stamatakis, M. Renedo, and D. Perez-Sala. 2005. Differential selectivity of protein modification by the cyclopentenone prostaglandins PGA1 and 15-deoxy-Delta12,14-PGJ2: role of glutathione. FEBS Lett. 579: 5803-5808.
44. Liu, J. D., S. H. Tsai, S. Y. Lin, Y. S. Ho, L. F. Hung, S. Pan, F. M. Ho, C. M. Lin, and Y. C. Liang. 2004. Thiol antioxidant and thiol-reducing agents attenuate 15-deoxy-delta 12,14-prostaglandin J2-induced heme oxygenase-1 expression. Life Sci. 74: 2451-2463.